Researcher.Life Logo

Revue Philosophique de Louvain : Impact Factor & More

eISSN: 1783-1768pISSN: 0035-3841

Aims and Scope of Revue Philosophique de Louvain

The Revue Philosophique de Louvain was founded in 1894 by Désiré Mercier as the Revue Néoscolastique. It is now published by the Institut Supérieur de Philosophie at the Catholic University of Louvain. The journals publishes on the international philosophical movements in the broadest sense. The journal is a source of research and discussion through its articles; a source of documentation and critics by its "bulletins", its book reviews and book notes; a source of information through its various chronicles. The Revue Philosophique de Louvain aims to be a working instrument as certain and complete as possible in the philosophical research field. Less

Key Metrics

CiteScore
0.2
SJR
Q3Philosophy
Recommended pre-submission checks
Powered by Paperpal by Editage

Revue Philosophique de Louvain Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PEETERS
Language French
Frequency Quarterly
General Details
LanguageFrench
FrequencyQuarterly
Publication Start Year1946
Website URLVisit website
View less

Planning to publish in Revue Philosophique de Louvain ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revue Philosophique de Louvain

Transforming Advanced Heart Failure Programs: Addressing Institutional and Systemic Drivers of Racial and Ethnic Disparities in Care.
  • 12 May 2026
  • Circulation. Heart failure
Big Data and Trustworthy AI for Heart Failure: A Review.
  • 11 May 2026
  • Circulation. Heart failure
Gene Therapy for Cardiomyopathy: Tools, Targets, and Trials.
  • 11 May 2026
  • Circulation. Heart failure
Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study.
  • 10 May 2026
  • Circulation. Heart failure
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.
  • 9 May 2026
  • Circulation. Heart failure
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).
  • 7 May 2026
  • Circulation. Heart failure
Transforming Advanced Heart Failure Programs: Addressing Institutional and Systemic Drivers of Racial and Ethnic Disparities in Care.
  • 12 May 2026
  • Circulation. Heart failure
Big Data and Trustworthy AI for Heart Failure: A Review.
  • 11 May 2026
  • Circulation. Heart failure
Gene Therapy for Cardiomyopathy: Tools, Targets, and Trials.
  • 11 May 2026
  • Circulation. Heart failure
Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study.
  • 10 May 2026
  • Circulation. Heart failure
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.
  • 9 May 2026
  • Circulation. Heart failure
Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).
  • 7 May 2026
  • Circulation. Heart failure

FAQs on Revue Philosophique de Louvain